Oncology News

Sen. Edward M. Kennedy will undergo surgery Monday at Duke University Medical Center for his cancerous brain tumor, his office said.

The 76-year-old senator was diagnosed last month with a malignant glioma, an especially lethal type of brain tumor. A statement from the Massachusetts Democrat's office said he would be operated on Monday morning in Durham, N.C., by neurosurgeon Allan Friedman, followed by chemotherapy and radiation. Anthony Coley, a Kennedy spokesman, said the surgery is expected to begin around 9 a.m. It is expected to last about six hours.

Comment?

Leading U.S. cancer scientists say that five years of flat federal funding of cancer research is threatening to undo major strides made against the disease.

Comment?

Scientists will have to figure out how to make stem cells grow if they're going to treat many diseases.

Comment?

For 48-year-old Steven Stello - whose father died of leukemia last year and who has just relapsed for the third time in 10 years with an incurable form of non-Hodgkin's lymphoma - there is need for hope.

Comment?

A Scottsdale startup company wants to create a social-networking site that could link doctors and pharmaceutical companies to help get cutting-edge cancer treatments to patients.

Comment?

Potential advances in the treatment of lung cancer, the leading cause of cancer deaths in the United States, will be a major focus at a key meeting of oncology specialists starting on Friday.

Comment?

The news did not make it to the front pages, but on Feb. 28 a powerful member of the U.S. Senate launched an attack on the Food and Drug Administration, the drug companies and the desperate cancer patients they ...

2 comments

ABC, CBS and NBC will donate an hour of commercial-free, prime-time television on Sept. 5 for a national broadcast to raise funds to fight cancer.

Comment?

All cancers are genetic in origin. When genes are working properly, cell growth is tightly regulated, as if a stoplight told cells to divide only so many times and no more.

Comment?

OneOncology Inc., a privately-held company working to create a transparent and open market for purchasing oncology drugs, today announced it has secured more than $2 billion in annual drug purchasing ...

Comment?